GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | -64.3% | 363 | -62.2% | 0.00% | -66.7% |
| Q1 2022 | $42,000 | +90.9% | 961 | +88.4% | 0.01% | +71.4% |
| Q4 2021 | $22,000 | +4.8% | 510 | -5.7% | 0.01% | 0.0% |
| Q3 2021 | $21,000 | 0.0% | 541 | +1.3% | 0.01% | -12.5% |
| Q2 2021 | $21,000 | +110.0% | 534 | +90.7% | 0.01% | +100.0% |
| Q1 2021 | $10,000 | +233.3% | 280 | +201.1% | 0.00% | +300.0% |
| Q4 2020 | $3,000 | -25.0% | 93 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $4,000 | 0.0% | 93 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |